Affinity Asset Advisors, LLC Pro Qr Therapeutics N.V. Transaction History
Affinity Asset Advisors, LLC
- $560 Million
- Q4 2024
A detailed history of Affinity Asset Advisors, LLC transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 2,825,000 shares of PRQR stock, worth $6.38 Million. This represents 1.38% of its overall portfolio holdings.
Number of Shares
2,825,000Holding current value
$6.38 Million% of portfolio
1.38%Shares
1 transactions
Others Institutions Holding PRQR
# of Institutions
73Shares Held
22.6MCall Options Held
37.7KPut Options Held
21.3K-
Privium Fund Management B.V.4.99MShares$11.3 Million3.12% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.63MShares$8.19 Million0.01% of portfolio
-
Ubs Group Ag2.31MShares$5.22 Million0.0% of portfolio
-
Platinum Investment Management LTD Sydney Australia 2000, C31.54MShares$3.48 Million0.25% of portfolio
-
M28 Capital Management LP Stamford, CT1.02MShares$2.3 Million2.26% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $161M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...